focus -WSS

focus

author：focus 2025-10-01 01:53:55 - browse：5348

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： PBM reform efforts get punted in Congress

focus

WSS

Alabama hospital puts IVF treatments on hold

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

The Harvard botanist who searched for psychedelics in the Amazon

How digital tools helped lower hypertension in marginalized patients

Vaccine advisory panel ACIP left half staffed by HHS

Alabama hospital puts IVF treatments on hold

focus

focus

knowledge

Medical records are filled with copy

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Hepatitis C has a cure — but many Americans still lack access to it

Gilead might be held responsible for not developing a drug

Sports medicine is finally prioritizing gender equality

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Medicare proposal to cover medical devices draws a mixed reaction

Medical mystery: When a cough is not just a cough

Wildfire smoke exposes gaps in outdoor worker protections

Key House Republican on health care plans exit from Congress

hotspot

To avoid data mishandling cases, universities eye AI and other tools

'Revelatory' study finds a smoking impact that remains after quitting

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Community Health Systems hospitals under DOJ investigation

Key House Republican on health care plans exit from Congress

The dental labor crisis is a moment of opportunity

focus

focus

hotspot

entertainment